InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Cooper Graham K, Directeur. Officer active across 1 company, notably Beam Therapeutics Inc.. In total, 2 disclosures have been logged. History available since 28 June 2021. The latest transaction was disclosed on 6 July 2021 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Cooper Graham K
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
2,614 股@ US$17.0018.0% 占其流量Common StockSEC:0000899243-21-027902:0
12,045 股@ US$17.0082.0% 占其流量Common StockSEC:0000899243-21-026782:0
2 条申报中的 2 条
About Cooper Graham K
Graham K. Cooper is a Director at Beam Therapeutics Inc. He plays a key role in the governance of the company, bringing his expertise to guide strategic decisions.
